Back to CVE records
High 8.6HealthcarePublished Jun 2, 2026

CVE-2022-4992Dräger Infinity M540 VG4.1.1 Spoofed Network Message Handling DoS/Tampering

Updated under an hour ago ()

Does this affect you?

It affects Dräger Infinity Acute Care System and 1 other product. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.16%, higher than 5% of scored CVEs.

Dräger Infinity Acute Care System and Standalone Infinity M540 patient monitors versions VG4.1.1, VG4.0.3, and lower (with VG4.2 partially affected) contain a network message handling vulnerability that allows remote attackers to inject spoofed or tampered data and cause denial-of-service conditions. Attackers can compromise network communications to modify device settings such as alarm states or alarm limits, or overwhelm the system with excessive network traffic causing the Cockpit or M540 to reboot and lose network functionality.

CVSS
8.6 HIGH (v3.1, CNA)CVSS:3.1/AV:N/AC:L/PR:N/UI:N/S:U/C:L/I:L/A:H
Weakness (CWE)
CWE-345
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.16% (percentile 5)
Assigned by
VulnCheck
NVD analysis
Awaiting Analysis
Record last updated
Jun 5, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
Dräger Infinity Acute Care System
drager:infinity_acute_care_system (from the name)
before VG4.2; before VG4.1.1; before VG4.0.3
CNA record
Dräger Standalone Infinity M540 patient monitor
drager:standalone_infinity_m540_patient_monitor (from the name)
before VG4.2; before VG4.1.1
CNA record

References

  • vendor-advisory
  • third-party-advisory

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.